News & Analysis on Clinical Trial Services & Contract Research And Development
The global cancer drug market is expected to reach $200bn by 2022 as the industry experiences rapid changes in treatment guidelines and pathways – and increasing complexity, says Iqvia exec.
Placebo capsules packaged out of order in Allergan’s Taytulla oral contraceptive blister pack have prompted a voluntary recall in the US.
Avara Pharmaceutical Services has agreed to buy Novartis’ sterile manufacturing facility and development centre in Quebec, Canada.
Braeburn has resubmitted its opioid use disorder candidate following the US FDA’s rejection in January.
The growing emphasis on personalized medicine is driving the need for biobanking services – demand for which is expected to continue increasing.
Academic research underpins many of the early success stories in continuous manufacturing. Now, Blair Brettmann and her team are working to write another chapter by applying electrospinning and other techniques to downstream processing.
Q&A
Combining mobile and web technologies with pharmaceutical medicines can drive “meaningful clinical impact,” says Canary Health CEO.